Insider Transactions in Q3 2021 at Verona Pharma PLC (VRNA)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 04
2021
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
18,400
-0.11%
|
$0
$0.74 P/Share
|
|
Aug 03
2021
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
33,656
-0.1%
|
$0
$0.76 P/Share
|
|
Aug 02
2021
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,416
-0.06%
|
$0
$0.77 P/Share
|
|
Aug 01
2021
|
Lisa Deschamps Director |
SELL
Payment of exercise price or tax liability
|
Direct |
11,664
-11.07%
|
$0
$0.78 P/Share
|
|
Aug 01
2021
|
David Zaccardelli President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
454,848
-2.55%
|
$0
$0.78 P/Share
|
|
Aug 01
2021
|
Mark W Hahn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
454,840
-2.69%
|
$0
$0.78 P/Share
|
|
Aug 01
2021
|
Claire Poll General Counsel |
BUY
Bona fide gift
|
Indirect |
360,400
+42.69%
|
-
|
|
Aug 01
2021
|
Claire Poll General Counsel |
SELL
Bona fide gift
|
Direct |
360,400
-14.75%
|
-
|
|
Aug 01
2021
|
Claire Poll General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
319,600
-11.57%
|
$0
$0.78 P/Share
|
|
Aug 01
2021
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
227,736
-7.43%
|
$0
$0.78 P/Share
|